Nektar Therapeutics (BMV:NKTR)
Mexico · Delayed Price · Currency is MXN 543.00
+129.00 (31.16%)
At close: Aug 28, 2025
Nektar Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| 74.93 | 98.43 | 90.12 | 92.06 | 101.91 | 152.92 | Upgrade | |
Revenue Growth (YoY) | -19.56% | 9.21% | -2.10% | -9.67% | -33.36% | 33.41% | Upgrade |
Cost of Revenue | 12.41 | 30.69 | 33.77 | 21.64 | 24.9 | 19.48 | Upgrade |
Gross Profit | 62.52 | 67.74 | 56.35 | 70.42 | 77.01 | 133.44 | Upgrade |
Selling, General & Admin | 77.51 | 76.75 | 77.42 | 92.33 | 122.84 | 104.68 | Upgrade |
Research & Development | 124.14 | 120.91 | 114.16 | 218.32 | 400.27 | 408.68 | Upgrade |
Other Operating Expenses | 2.02 | 56.06 | 128.46 | 135.93 | - | 45.19 | Upgrade |
Operating Income | -141.15 | -185.98 | -263.68 | -376.17 | -446.1 | -425.11 | Upgrade |
Interest Income | 11.22 | 14.5 | 19.01 | 6.78 | 2.73 | 18.28 | Upgrade |
Interest Expense | -26.54 | -28.11 | -25.33 | -28.91 | -47.31 | -37.12 | Upgrade |
Other Non-Operating Income (Expense) | 0.27 | -0.39 | -6.25 | 33.31 | -32.6 | - | Upgrade |
Total Non-Operating Income (Expense) | -15.05 | -14 | -12.57 | 11.18 | -77.18 | -18.84 | Upgrade |
Pretax Income | -156.2 | -199.98 | -276.26 | -364.98 | -523.28 | -443.95 | Upgrade |
Provision for Income Taxes | -0.39 | -0.24 | -0.2 | 3.22 | 0.56 | 0.49 | Upgrade |
Net Income | -122.27 | -118.96 | -276.06 | -368.2 | -523.84 | -444.44 | Upgrade |
Net Income to Common | -122.27 | -118.96 | -276.06 | -368.2 | -523.84 | -444.44 | Upgrade |
Shares Outstanding (Basic) | 14 | 14 | 13 | 12 | 12 | 12 | Upgrade |
Shares Outstanding (Diluted) | 14 | 14 | 13 | 12 | 12 | 12 | Upgrade |
Shares Change (YoY) | 7.16% | 8.24% | 1.53% | 2.10% | 2.64% | 2.05% | Upgrade |
EPS (Basic) | -8.65 | -8.70 | -21.75 | -29.55 | -42.90 | -37.35 | Upgrade |
EPS (Diluted) | -8.65 | -8.70 | -21.75 | -29.55 | -42.90 | -37.35 | Upgrade |
Free Cash Flow | -186.07 | -177.18 | -193.47 | -309.68 | -427.65 | -320.55 | Upgrade |
Free Cash Flow Per Share | -13.27 | -12.92 | -15.27 | -24.82 | -35.00 | -26.92 | Upgrade |
Gross Margin | 83.44% | 68.82% | 62.53% | 76.50% | 75.57% | 87.26% | Upgrade |
Operating Margin | -188.37% | -188.95% | -292.59% | -408.63% | -437.76% | -278.00% | Upgrade |
Profit Margin | -207.93% | -202.93% | -306.31% | -399.98% | -514.03% | -290.65% | Upgrade |
FCF Margin | -248.32% | -180.01% | -214.68% | -336.41% | -419.65% | -209.62% | Upgrade |
EBITDA | -139.19 | -181.59 | -255.87 | -363.14 | -431.96 | -410.93 | Upgrade |
EBITDA Margin | -185.75% | -184.49% | -283.91% | -394.48% | -423.87% | -268.73% | Upgrade |
EBIT | -141.15 | -185.98 | -263.68 | -376.17 | -446.1 | -425.11 | Upgrade |
EBIT Margin | -188.37% | -188.95% | -292.59% | -408.63% | -437.76% | -278.00% | Upgrade |
Effective Tax Rate | 0.25% | 0.12% | 0.07% | -0.88% | -0.11% | -0.11% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.